Quantic Nanotech S.L. wins Global 100 award for innovative product for the treatment of rheumatism and osteoarthritis
Spanish company Quantic Nanotech S.L., a division of DEMAC S.A., has been awarded the prestigious Global 100 award in the category of “Most Innovative Digital Health Product for Rheumatism and Osteoarthritis” for the year 2025. This recognition highlights the company’s groundbreaking contribution to the field of digital health solutions, specifically in the treatment of rheumatic and osteoarthritic diseases.
The Quantic Electronic Glove System: A revolution in home treatment
Quantic Nanotech’s flagship product is the Quantic Glove System, an advanced electronic glove designed to alleviate pain and joint stiffness associated with osteoarthritis in the hands. This state-of-the-art device integrates multiple therapeutic modalities, including:
– Dry heat therapy
– Mechanical micropulses
– Passive stretching
All of these functions are controlled through an automated electronic interface. The system is complemented by disposable gloves impregnated with high quality natural ingredients such as argan oil, calendula, purslane and horse chestnut, which provide anti-inflammatory benefits and improve overall hand health.
Clinical validation and international recognition
The efficacy of the Quantic Glove System has been supported by rigorous clinical trials. In December 2022, the results of an open-label multicenter clinical trial were presented at the Congress of the Rheumatology Society of the Community of Madrid (SORCOM). The study demonstrated significant improvements in pain reduction and functional capacity in patients with hand osteoarthritis.
A legacy of innovation
Founded in 1992 by a team of visionary engineers led by Mr. Jose Luis de la Torre, DEMAC S.A. has consistently prioritized research and development in various sectors. Quantic Nanotech, as a specialized division, embodies this philosophy by focusing on health-related technologies.
Looking to the future
With this prestigious recognition, Quantic Nanotech is preparing to expand its product offering and explore new therapeutic avenues. Collaborations with medical institutions and ongoing research initiatives aim to improve the efficacy of existing treatments and develop innovative solutions that improve the quality of life of people affected by rheumatic and osteoarthritic diseases.
This award consolidates Quantic Nanotech’s position as a leader in innovation in the field of digital health, especially in the treatment of rheumatic and osteoarthritic diseases, and bodes well for the Spanish company’s future in the global medical technology market.
